Literature DB >> 2152210

Use of two recombinant proteins of Trypanosoma cruzi in the serological diagnosis of Chagas disease.

B Zingales1, A Gruber, C B Ramalho, E S Umezawa, W Colli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2152210     DOI： 10.1590/s0074-02761990000400024

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN： 0074-0276            Impact factor:   2.743


× No keyword cloud information.
  5 in total

1.  Excretory-secretory antigens of Trypanosoma cruzi are potentially useful for serodiagnosis of chronic Chagas' disease.

Authors:  M Nakazawa; D S Rosa; V R Pereira; M O Moura; V C Furtado; W V Souza; M N Barros; F G Abath; Y M Gomes
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Serological confirmation of Chagas' disease by a recombinant and peptide antigen line immunoassay: INNO-LIA chagas.

Authors:  A Saez-Alquézar; E C Sabino; N Salles; D F Chamone; F Hulstaert; H Pottel; E Stoops; M Zrein
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America.

Authors:  E S Umezawa; S F Bastos; M E Camargo; L M Yamauchi; M R Santos; A Gonzalez; B Zingales; M J Levin; O Sousa; R Rangel-Aldao; J F da Silveira
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease.

Authors:  Mariolga Berrizbeitia; Momar Ndao; José Bubis; Marcelo Gottschalk; Alberto Aché; Sonia Lacouture; Mehudy Medina; Brian J Ward
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Trypanosoma cruzi recombinant complement regulatory protein: a novel antigen for use in an enzyme-linked immunosorbent assay for diagnosis of Chagas' disease.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.